The page is the record's research on the issuer — no analyst, no rating, no view. # GH Research PLC (NASDAQ: GHRS) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing GH Research PLC is listed on NASDAQ under the ticker GHRS, with ISIN USG3855L1064. The record does not hold an LEI for the issuer, as no GLEIF record carries the exact legal name in jurisdiction US-L2. The security type is recorded as non-operating entity type (other), the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is Ireland. The issuer is listed and not halted. ## The disclosure read The record holds 49 filings in the twelve months to 2026-11-08, across 32 filing days, comprising 22 results, 12 directors' dealings, 12 regulatory filings and 3 prospectuses. The median gap between filing days is 7 days. The latest filing is a regulatory filing dated 2026-11-05, 3 days before the record date. On NASDAQ the median cadence gap is 6.0 days across 4359 issuers, with a median of 52 filings and a median latency of 5.0 days. In the sector 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days across 526 issuers, with a median of 63.0 filings and a median latency of 4.0 days. ## Auditor The auditor of record is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and foreign private issuers and older filings carry none. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The orderability outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record seals the issuer's years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001855129.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/GHRS (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/GHRS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/GHRS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp